The MTHFR C677T genetic susceptibility and its role in risk prediction for type 2 diabetic nephropathy in Northern China

MTHFR C677T基因易感性及其在中国北方地区2型糖尿病肾病风险预测中的作用

阅读:2

Abstract

OBJECTIVE: Diabetic nephropathy is a diabetes-induced chronic kidney disease characterized by pathological changes that may involve the entire renal structure and can progress to end-stage renal disease, thereby substantially impairing patients' quality of life. The MTHFR C677T gene polymorphism has been closely associated with the development of diabetic nephropathy through its regulatory effect on homocysteine levels. Evidence suggests that both the MTHFR C677T genetic variant and other clinical or environmental risk factors may interactively contribute to disease susceptibility. This study investigated the genetic predisposition conferred by MTHFR C677T and its interaction with modifiable risk factors among patients with diabetic nephropathy in northern China, aiming to establish a region-specific risk prediction model for improved early identification and prevention. MATERIAL AND METHODS: From January 2018 to 2024, a total of 397 patients with type 2 diabetes were selected from the Second Hospital of Shanxi Medical University. Among them, 153 cases were diagnosed as diabetic nephropathy group (DN group), and the remaining 244 cases were control group (N-DN group). The clinical data of these patients were extracted from electronic medical records. The biochemistry index, including homocysteine (Hcy) were collected from the hospital laboratory test system and the polymorphism of MTHFR C677T gene was analyzed by polymerase chain reaction (PCR) test. The risk prediction model of diabetic nephropathy was established by Logistic regression. RESULTS: MTHFR C677T gene polymorphism was closely related to diabetic nephropathy. The proportion of 677TT genotype (57.52%) and the homocysteine concentration in DN group were significantly higher than those in N-DN group, and the circulating homocysteine concentration in 677TT genotype (17.29 ± 8.95 μmol/L) was significantly higher than that in 677CT genotype (13.08 ± 6.20 μmol/L) and 677CC genotype (12.65 ± 4.35 μmol/L) (P < 0.001). The carriers of MTHFR677CT and MTHFR677TT genotypes could increase 3.298-fold and 12.713-fold risk of having DN respectively compared with the carriers of 677CC genotype.In addition, the diabetic peripheralangiopathy, the diabetic retinopathy, triglyceride(TG), HOMA-IR, HCY(16-30μmol/L), HCY(>30μmol/L), Blood urea nitrogen(BUN), urinary microalbumin creatinine ratio (ACR) were independent risk factors for diabetic retinopathy (OR = 2.462, 4.572, 1.548, 1.133, 1.571,1.379,1.254,1.003). The above eight factors constitute the Nomogram risk prediction model of DN with good test performance and discriminant ability. CONCLUSION: MTHFR C677T genotype, Hcy, the diabetic peripheralangiopathy, the diabetic retinopathy, triglyceride(TG), HOMA-IR, Blood urea nitrogen(BUN), urinary microalbumin creatinine ratio (ACR)diabetic retinopathy were independent factors for diabetic nephropathy, which would help to identify the risk of diabetic nephropathy and provide the basis for the development of diabetic nephropathy control strategies and treatment measures.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。